Trials / Completed
CompletedNCT01953679
Efficacy Study of Two Continuous Regimens of Oral Daily 5 mg or 10 mg of Ulipristal Acetate (UPA), Versus a Dose of 5.0mg UPA for 24/4 Days
A Phase IIb Randomized, Double Blind, Comparative Study to Assess the Efficacy, Safety, Tolerability and Inhibition of Ovulation of Two Continuous Regimens of Oral Daily 5 mg or 10 mg of Ulipristal Acetate (UPA), Versus a Dose of 5.0mg UPA for 24/4 Days
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 180 (actual)
- Sponsor
- Premier Research · Academic / Other
- Sex
- Female
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
To compare the pharmacodynamic effects of 2 continuous dose regimens of ulipristal acetate 5.0 and 10.0 mg-only oral contraception, versus a 24/4 day regimen of UPA 5.0 mg.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ulipristal Acetate |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2015-08-01
- Completion
- 2015-11-01
- First posted
- 2013-10-01
- Last updated
- 2016-02-22
Locations
10 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01953679. Inclusion in this directory is not an endorsement.